Delivery Order SPE2DB20D3103-SPE2DB22FM5T9
- Not listed
- This federal contract award, valued at $3,764.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of insulin aspart 100 unit/mL pens. The contract is a delivery order placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award is for the delivery of Insulin Aspart 100 Unit/mL pens to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract has a ceiling value of $18,732.80 and is a delivery order with a firm fixed price. The ultimate completion date is January 24, 2024. There is no set-aside designation for this contract, indicating it...
- The Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $2,195.52, is for the provision of Insulin Aspart 100 unit/mL pens with a completion date of January 31, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this delivery order, which is part of a larger indefinite delivery...
- The federal contract award, valued at $1,351.79, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as a firm fixed price delivery order. The contract is for the supply of insulin aspart 100 unit/ml pens with a completion date of March 14, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December...
- This federal contract award is for the delivery of insulin aspart 100 unit/ml pen, 3 ml, to the Defense Logistics Agency (DLA). The $4,863.40 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a period of performance through January 11, 2024 and was not set aside for any specific small business designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $11,977.56 to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4,562,896,805 units of insulin aspart 100 unit/mL pens. This contract has a period of performance through November 27, 2023 and was awarded on November 24, 2023. The contract is not designated with a set-aside requirement. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of insulin aspart 100 unit/mL pens. The contract, valued at $3,193.71, is a firm fixed-price delivery order with a completion date of July 30, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, for providing a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $9,088.30 firm-fixed-price delivery order is for the supply of Insulin Aspart 100 unit/mL pens. This order is a part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
- This federal contract award is for the delivery of insulin aspart 100 unit/mL pens (3 mL) to the Defense Logistics Agency (DLA), a defense agency. The $6,552.33 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,393.62, is for the delivery of Insulin Aspart 100 Unit/mL Pen 3mL. The award has an ultimate completion date of April 30, 2024 and is a Firm Fixed Price Delivery Order contract. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FM5T9Delivery Order
This federal contract award is a delivery order (SPE2DB22FM5T9) for insulin aspart 100 unit/ml pens (3 ml) worth $4,233.36. The contract was awarded on February 7, 2022, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 2/7/22 |